BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15837826)

  • 1. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome.
    Wang JG; Staessen JA; Franklin SS; Fagard R; Gueyffier F
    Hypertension; 2005 May; 45(5):907-13. PubMed ID: 15837826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modeling of systolic blood pressure reaction to antihypertensive agents in people with hypertension].
    Wu Y; Li YS; Bejan-Angoulvant T; Gueyffier F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):309-14. PubMed ID: 21624305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated systolic hypertension in the elderly: lessons from clinical trials and future directions.
    Black HR
    J Hypertens Suppl; 1999 Dec; 17(5):S49-54. PubMed ID: 10706327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy.
    Zanchetti A; Hansson L; Leonetti G; Rahn KH; Ruilope L; Warnold I; Wedel H
    J Hypertens; 2002 May; 20(5):1015-22. PubMed ID: 12011664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Blood Pressure Measurements With Peripheral Artery Disease Events.
    Itoga NK; Tawfik DS; Lee CK; Maruyama S; Leeper NJ; Chang TI
    Circulation; 2018 Oct; 138(17):1805-1814. PubMed ID: 29930023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
    Blood Pressure Lowering Treatment Trialists' Collaboration
    Lancet; 2021 Sep; 398(10305):1053-1064. PubMed ID: 34461040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of some parameters on the blood pressure reduction under treatment: experience from the Hypertension Optimal Treatment Study].
    Mallion JM; Baguet JP; Siché JP; Benkritly A
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1049-53. PubMed ID: 9749163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
    Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
    Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target.
    Mourad JJ
    Vasc Health Risk Manag; 2008; 4(6):1315-25. PubMed ID: 19337545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional antihypertensive drug therapy does not prevent the increase of pulse pressure with age.
    Mourad JJ; Blacher J; Blin P; Warzocha U;
    Hypertension; 2001 Oct; 38(4):958-61. PubMed ID: 11641317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular protection and blood pressure reduction: a meta-analysis.
    Staessen JA; Wang JG; Thijs L
    Lancet; 2001 Oct; 358(9290):1305-15. PubMed ID: 11684211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive therapy in the elderly: results of large trials].
    Leonetti G; Cuspidi C; Facchini M
    Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of diastolic blood pressure when treating isolated systolic hypertension.
    Somes GW; Pahor M; Shorr RI; Cushman WC; Applegate WB
    Arch Intern Med; 1999 Sep; 159(17):2004-9. PubMed ID: 10510985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.